Nature Medicine, Published online: 29 May 2025; doi:10.1038/d41591-025-00034-8GLP-1 receptor agonist semaglutide significantly outperformed placebo in an ongoing phase 3 trial,
Nature Medicine, Published online: 29 May 2025; doi:10.1038/d41591-025-00035-7Researchers studied the antibody library of a venom-immune person with extensive snakebite exposure
NEW YORK, May 29, 2025 /PRNewswire/ -- Leading eye care company SCOPE Health Inc. proudly introduces its latest acquisitions, further
SYDNEY, May 29, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission
Emerging as a next-generation vaccine amidst global resurgence of COVID-19 Expanding various pipelines other than universal COVID vaccine SEOUL, South
Bringing Science-Backed Skeletal Strengthening Technology to Puerto Rico GUAYNABO, Puerto Rico, May 29, 2025 /PRNewswire/ -- OsteoStrong, a global leader
JUNO BEACH, Fla., May 29, 2025 /PRNewswire/ -- Juno Health, an organization at the forefront of healthcare innovation and digital
In a world increasingly driven by sustainability and conscious consumerism, the appeal of vintage and
… Osei Bonsu, the Municipal Agricultural Officer, who made the … difficult for farmers and Agricultural officers.”
Todd Surdey will head Maxar’s business enterprise segment The post Maxar Intelligence taps tech veteran to lead commercial business appeared first
